DLA Piper advised Cantor Fitzgerald on the transaction. The transaction consisted in an offer to exchange certain outstanding warrants to purchase Class A ordinary shares of...
Zura Bio’s Warrant Exchange Offer and Consent Solicitation
Haemonetics’ US$160 Million Acquisition of Attune Medical
DLA Piper represented Haemonetics Corporation in the transaction. Haemonetics Corporation (Haemonetics), a global medical technology company focused on delivering innovative medical solutions to drive better patient...
BillingPlatform’s US$90 Million Equity Growth Investment
DLA Piper represented BillingPlatform in the transaction. BillingPlatform, an enterprise revenue lifecycle management solutions provider, secured a significant US$90 million growth equity investment from FTV Capital, a...
GAN Integrity’s Series C Financing Round
DLA Piper advised GAN Integrity Holdings on the transaction. GAN Integrity Holdings (“GAN”), a pioneer of no-code risk, ethics, and compliance management technology, announced its Series C...
Rosemont Investment Group’s Minority Equity Investment in Landmark Management
Cozen O’Connor served as legal representative to Rosemont and DLA Piper served as legal representative to Landmark in the transaction. Landmark Management, LLC (Landmark), a multi-family...